Literature DB >> 30554085

Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson's disease.

Xiaojun Guan1, Yuyao Zhang2, Hongjiang Wei2, Tao Guo3, Qiaoling Zeng3, Cheng Zhou3, Jiaqiu Wang4, Ting Gao4, Min Xuan3, Quanquan Gu3, Xiaojun Xu3, Peiyu Huang3, Jiali Pu4, Baorong Zhang4, Chunlei Liu5, Minming Zhang6.   

Abstract

In Parkinson's disease (PD), iron accumulation in the substantia nigra (SN) exacerbates oxidative stress and α-synuclein aggregation, leading to neuronal death. However, the influence of iron-related nigral degeneration on the subcortical function and global network configuration in PD remains unknown. Ninety PD patients and 38 normal controls underwent clinical assessments and multimodality magnetic resonance imaging scans. Iron accumulation in the inferior SN and disrupted functional connectivity between the bilateral striatums were observed in PD, and negative correlation between them was found in the whole population. The binarized functional network exhibited enhanced global efficiency and reduced local efficiency while the weighted functional network exhibited reduction in both, and both changes were correlated with nigral iron accumulation in PD. Mediation analysis demonstrated that the functional connectivity between bilateral striatums was a mediator between the nigral iron accumulation and weighted functional network alterations. In conclusion, our findings reveal that iron-related nigral degeneration possibly influences the functional topology mediated by striatal dysfunction, which extends the scientific understanding of PD pathogenesis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diffusion tensor imaging; Functional magnetic resonance imaging; Iron; Parkinson's disease; Quantitative susceptibility mapping

Mesh:

Substances:

Year:  2018        PMID: 30554085      PMCID: PMC6538269          DOI: 10.1016/j.neurobiolaging.2018.11.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  86 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Pathophysiology of the basal ganglia in Parkinson's disease.

Authors:  J A Obeso; M C Rodríguez-Oroz; M Rodríguez; J L Lanciego; J Artieda; N Gonzalo; C W Olanow
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

3.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

5.  The effect of age on the non-haemin iron in the human brain.

Authors:  B HALLGREN; P SOURANDER
Journal:  J Neurochem       Date:  1958-10       Impact factor: 5.372

6.  SPSS and SAS procedures for estimating indirect effects in simple mediation models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods Instrum Comput       Date:  2004-11

7.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

8.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

9.  Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes.

Authors:  L Zecca; M Gallorini; V Schünemann; A X Trautwein; M Gerlach; P Riederer; P Vezzoni; D Tampellini
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

Review 10.  The human connectome: A structural description of the human brain.

Authors:  Olaf Sporns; Giulio Tononi; Rolf Kötter
Journal:  PLoS Comput Biol       Date:  2005-09       Impact factor: 4.475

View more
  15 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 2.  Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research.

Authors:  Peiyu Huang; Minming Zhang
Journal:  Neurosci Bull       Date:  2022-06-30       Impact factor: 5.203

3.  The protective role of cigarette smoking against Parkinson's disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms.

Authors:  Quanquan Gu; Xiaocao Liu; Qingze Zeng; Xiaojun Guan; Cheng Zhou; Tao Guo; Baorong Zhang; Minming Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-07

Review 4.  Global Alterations of Whole Brain Structural Connectome in Parkinson's Disease: A Meta-analysis.

Authors:  Chao Zuo; Xueling Suo; Huan Lan; Nanfang Pan; Song Wang; Graham J Kemp; Qiyong Gong
Journal:  Neuropsychol Rev       Date:  2022-09-20       Impact factor: 6.940

5.  Normalization effect of levodopa on hierarchical brain function in Parkinson's disease.

Authors:  Tao Guo; Min Xuan; Cheng Zhou; Jingjing Wu; Ting Gao; Xueqin Bai; Xiaocao Liu; Luyan Gu; Ruiqi Liu; Zhe Song; Quanquan Gu; Peiyu Huang; Jiali Pu; Baorong Zhang; Xiaojun Xu; Xiaojun Guan; Minming Zhang
Journal:  Netw Neurosci       Date:  2022-06-01

6.  A multiple-tissue-specific magnetic resonance imaging model for diagnosing Parkinson's disease: a brain radiomics study.

Authors:  Xiao-Jun Guan; Tao Guo; Cheng Zhou; Ting Gao; Jing-Jing Wu; Victor Han; Steven Cao; Hong-Jiang Wei; Yu-Yao Zhang; Min Xuan; Quan-Quan Gu; Pei-Yu Huang; Chun-Lei Liu; Jia-Li Pu; Bao-Rong Zhang; Feng Cui; Xiao-Jun Xu; Min-Ming Zhang
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

Review 7.  Nrf2 as a potential target for Parkinson's disease therapy.

Authors:  Yingcai Niu; Jing Zhang; Miaoxian Dong
Journal:  J Mol Med (Berl)       Date:  2021-04-12       Impact factor: 4.599

8.  Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease.

Authors:  Zhenxiang Zang; Tianbin Song; Jiping Li; Shaozhen Yan; Binbin Nie; Shanshan Mei; Jie Ma; Yu Yang; Baoci Shan; Yuqing Zhang; Jie Lu
Journal:  Hum Brain Mapp       Date:  2022-04-26       Impact factor: 5.399

Review 9.  Oscillation-specific nodal alterations in early to middle stages Parkinson's disease.

Authors:  Xiaojun Guan; Tao Guo; Qiaoling Zeng; Jiaqiu Wang; Cheng Zhou; Chunlei Liu; Hongjiang Wei; Yuyao Zhang; Min Xuan; Quanquan Gu; Xiaojun Xu; Peiyu Huang; Jiali Pu; Baorong Zhang; Min-Ming Zhang
Journal:  Transl Neurodegener       Date:  2019-11-15       Impact factor: 8.014

10.  Clinically relevant connectivity features define three subtypes of Parkinson's disease patients.

Authors:  Tao Guo; Xiaojun Guan; Cheng Zhou; Ting Gao; Jingjing Wu; Zhe Song; Min Xuan; Quanquan Gu; Peiyu Huang; Jiali Pu; Baorong Zhang; Feng Cui; Shunren Xia; Xiaojun Xu; Minming Zhang
Journal:  Hum Brain Mapp       Date:  2020-06-26       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.